Business Wire

WhereScape Announces Cloud Data Warehouse Automation for Snowflake


WhereScape, the leading provider of data infrastructure automation software, today announced WhereScape® automation for Snowflake, an offering designed to help IT organizations speed up the delivery of cloud-based data infrastructure projects. WhereScape will showcase the new offering this week during the TDWI Conference in Anaheim, Calif.

WhereScape automation for Snowflake automates key development and operations workflows for Snowflake customers based on the native functions, wizards and best practices of Snowflake and incorporates data warehouse modelling methodologies such as 3NF, dimensional and Data Vault 2.0. Snowflake provides cloud-based data warehousing solutions that deliver the performance, elasticity, scalability, concurrency and simplicity needed to store and analyze all of an organization’s data in one location.

“The combination of WhereScape’s data warehouse automation tools with Snowflake's zero administration service is perfect for enabling our customers to be successful with agile data warehousing,” said Kent Granziano, senior technical evangelist of Snowflake. “WhereScape automation for Snowflake makes it possible for organizations to start using Snowflake faster and more easily by simplifying and automating the design, build and population of data warehouse tables. Our customers will benefit from the effortless, simple, drag and drop interface, with which they can point at a source database, or even flat files, then load that data right into Snowflake with zero coding! That is agile.”

“Our health and life sciences clients rely on us to execute flawless marketing campaigns and deliver customer insights from across our many digital platforms,” said Peter Nilsson, Chief Technology Officer of Aptus Health. “To that end, we’re leveraging WhereScape’s ability to ease our design and implementation effort as we develop our fully-integrated warehouse on Snowflake. WhereScape's tools will save us thousands of engineering hours, promote implementation accuracy, and accelerate our time to delivery. And since WhereScape natively supports Snowflake, we can use the generated code without having to tailor it to our target environment—letting us focus on generating the insights that will drive our business forward.”

WhereScape automation for Snowflake includes:

  • WhereScape® 3D for Snowflake helping IT teams quickly and effectively tackle the upfront planning, modelling and design needed to rapidly put Snowflake to use. WhereScape 3D data discovery and profiling tools allow customers to more easily understand new data sources and leverage automation built for Snowflake to quickly build, test and iterate on prototypes with business users.
  • WhereScape® RED for Snowflake, an integrated development environment, providing IT teams the ability to develop, deploy and operate Snowflake data infrastructure faster. With built-in automation based on native Snowflake functions, wizards and best practices, customers can eliminate the time-intensive hand-coding involved in data infrastructure development. Advanced DevOps capabilities allow users to quickly establish new environments, continuously migrate changes and operate data processing in Snowflake – all with best practices automatically utilized. WhereScape RED for Snowflake automatically generates and maintains user and technical documentation such as data lineage, track back, and track forward for future reference, lifting a time-intensive burden off IT teams.
  • WhereScape® Data Vault Express™ for Snowflake, an integrated combination of WhereScape 3D and WhereScape RED embedded with Data Vault 2.0 specific capabilities, empowering teams to more practically deliver data vaults.

"Whether large or small, organizations today are grappling with the strategy, tactics and timing of moving on-premises data into the cloud," said Matt Aslett, Research Director of 451 Research. "Automating data movement and populating data warehouse tables in the cloud promises to smooth the transition path for IT teams, providing more time to focus on the business value of the transition and associated analytics applications.”

“IT faces enormous pressure to deliver decision-support information faster than ever before,” said Mark Budzinski, CEO of WhereScape. “As the growth of data doubles nearly every other year, organizations are increasingly feeling squeezed for resources and time. Many look to the cloud to address these challenges. We are excited to help Snowflake customers maximize their adoption of a cloud strategy and fast-track their use of Snowflake by addressing head-on the thrash and hidden costs of designing, developing, deploying and operating data infrastructure.”

Mark Budzinski, CEO of WhereScape, and Jon Bock, VP of product and partner marketing for Snowflake Computing, will discuss the offering together today on the #InsideAnalysis radio podcast at 3PM ET, with a follow-up Deep Dive Webcast at 4PM ET. Additionally, WhereScape’s Jason Laws, vice president of product management, will present today at the TDWI Leadership Summit at 2:15PM PT.

Learn more about WhereScape automation for Snowflake here
WhereScape #InsideAnalysis podcast and Deep Dive webcast here

About WhereScape

WhereScape helps IT organizations of all sizes leverage automation to design, develop, deploy, and operate data infrastructure faster. More than 700 customers worldwide rely on WhereScape automation to eliminate hand-coding and other repetitive, time-intensive aspects of data infrastructure projects to deliver data warehouses, vaults, lakes and marts in days or weeks rather than in months or years. WhereScape has offices in Portland, Oregon; Reading, UK; Auckland, New Zealand; and Singapore. For more information, please visit

All products or company names herein may be trademarks of their respective owners.

Contact information

Ruth Armitage/Sarah Shkargi

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 21:28Tiedote

Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (, a leading German electronics publication. This press release features multimedia. View the full release here: Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl

Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 19:05Tiedote

Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the

Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 15:52Tiedote

Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal

CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 15:50Tiedote

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation

Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 15:46Tiedote

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c

Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 15:00Tiedote

Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at This press release features multimedia. View the full release here: Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme